Processa Pharmaceuticals, Inc. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Processa Pharmaceuticals, Inc. stock issued during period, value, conversion of units for the quarter ending 2019-09-30 was $258.93K.
- Processa Pharmaceuticals, Inc. stock issued during period, value, conversion of units for the quarter ending 2018-12-31 was -$77.76K.
- Processa Pharmaceuticals, Inc. stock issued during period, value, conversion of units for the quarter ending 2018-09-30 was $0.00.
- Processa Pharmaceuticals, Inc. stock issued during period, value, conversion of units for the quarter ending 2018-06-30 was $2.39M.
- Processa Pharmaceuticals, Inc. stock issued during period, value, conversion of units for fiscal 2019 was $258.93K, a 88.80% decline from fiscal 2018.
- Processa Pharmaceuticals, Inc. stock issued during period, value, conversion of units for fiscal 2018 was $2.31M.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2019-12-31 | $258.93K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $258.93K 10-Q · filed 2020-11-12 | |
| 2018-12-31 | -$77.76K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $2.31M 10-K · filed 2020-03-06 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | |
| 2018-06-30 | $2.39M 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |